<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments</h1>
    <p class="timestamp">Published: 2020-05-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments," and an opportunity for public comment. This public meeting will take place virtually due to extenuating circumstances and will be held by webcast only.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-11306</p>
    <p><strong>Publication Date:</strong> 2020-05-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/05/27/2020-11306/financial-transparency-and-efficiency-of-the-prescription-drug-user-fee-act-biosimilar-user-fee-act">https://www.federalregister.gov/documents/2020/05/27/2020-11306/financial-transparency-and-efficiency-of-the-prescription-drug-user-fee-act-biosimilar-user-fee-act</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-11306</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
